Interprofessional Training to Improve Diabetes Care: The ReSPECT Trial (ReSPECT)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00854594 |
Recruitment Status
:
Completed
First Posted
: March 3, 2009
Results First Posted
: October 6, 2015
Last Update Posted
: October 6, 2015
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Diabetes Mellitus | Behavioral: Role modeling in Shared medical appointments to Promote Establishing Collaborative Teams (ReSPECT) | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 117 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Prevention |
Official Title: | Interprofessional Training for Improving Diabetes Care |
Study Start Date : | September 2010 |
Actual Primary Completion Date : | May 2013 |
Actual Study Completion Date : | September 2013 |
Arm | Intervention/treatment |
---|---|
No Intervention: Control
Control sites will receive the baseline measures pre and post. These sites will receive traditional diabetes education, which includes teleconsultation.
|
|
Experimental: ReSPECT Intervention
Intervention sites will receive baseline measures pre and post, but also in-depth Shared Medical Appointments (SMA)(The Role modeling in Shared medical appointments to Promote Establishing Collaborative Teams (ReSPECT) intervention) and at 15 months SMA video conferences. At the end of the 18 months the randomly selected patients and providers will be asked to take part in a qualitative interview.
|
Behavioral: Role modeling in Shared medical appointments to Promote Establishing Collaborative Teams (ReSPECT)
The intervention is designed to educate the clinicians at intervention CBOCs by modeling interprofessional team practices during SMAs for diabetes mellitus (DM) patients from each CBOC primary care provider's (PCP) patient panel. We hypothesize that this education at intervention CBOCs will improve interprofessional practices and overall quality care delivered to veterans.
Other Name: ReSPECT
|
- Provider Abilities Scale - Subscale From the Midwest (MW) Clinicians' Network [ Time Frame: Baseline ]
Providers asked to indicate their level of confidence on an 11-point scale, with 0 indicating 'not at all confident' and 10 indicating 'extremely confident' for the following activities:
- Instruct patients on home glucose monitoring
- Teach foot care
- Teach insulin administration
- Instruct patients about diet
- Help patients make changes in their diets that you have recommended
- Instruct patients about regular exercise
- Help patients make changes in their exercise habits that you have recommended
- Identify candidates for long-acting insulin
- Interpret glucose patterns
- Adjust insulin in insulin-treated patients with poor glycemic control
- Do you feel comfortable knowing whether to titrate basal insulin versus bolus insulin
- Manage patients with poor glycemic control
- Initiate insulin therapy (NPH or insulin glargine and aspart)
- Apply principles of diabetes care in a team setting
Averages of provider efficacy were calculated across all activities.
- Provider Abilities Scale - Subscale From the Midwest (MW) Clinicians' Network [ Time Frame: 22 months (post-intervention) ]
Providers asked to indicate their level of confidence on an 11-point scale, with 0 indicating 'not at all confident' and 10 indicating 'extremely confident' for the following activities:
- Instruct patients on home glucose monitoring
- Teach foot care
- Teach insulin administration
- Instruct patients about diet
- Help patients make changes in their diets that you have recommended
- Instruct patients about regular exercise
- Help patients make changes in their exercise habits that you have recommended
- Identify candidates for long-acting insulin
- Interpret glucose patterns
- Adjust insulin in insulin-treated patients with poor glycemic control
- Do you feel comfortable knowing whether to titrate basal insulin versus bolus insulin
- Manage patients with poor glycemic control
- Initiate insulin therapy (NPH or insulin glargine and aspart)
- Apply principles of diabetes care in a team setting
Averages of provider efficacy were calculated across all activities.
- Attitudes Toward Healthcare Teams Scale and Subscales [ Time Frame: Baseline ]A validated scale developed to assess attitudes towards teams in a healthcare setting with three subscales to assess attitudes toward team value, attitudes toward team efficiency, and attitudes towards physician's shared role on a team. Each of the 21 items is rated 1 to 6, ranging from 'Strongly Disagree' to 'Strongly Agree'. The scale was considered 'complete' for analysis among providers who answered at least 7 of the 21 items. Items were reverse-coded as specified in the subscale development publication. Averages across completed items were calculated within provider. Higher values corresponded with more positive attitudes towards teams.
- Attitudes Toward Healthcare Teams Scale and Subscales [ Time Frame: 22 months (post-intervention) ]A validated scale developed to assess attitudes towards teams in a healthcare setting with three subscales to assess attitudes toward team value, attitudes toward team efficiency, and attitudes towards physician's shared role on a team. Each of the 21 items is rated 1 to 6, ranging from 'Strongly Disagree' to 'Strongly Agree'. The scale was considered 'complete' for analysis among providers who answered at least 7 of the 21 items. Items were reverse-coded as specified in the subscale development publication. Averages across completed items were calculated within provider. Higher values corresponded with more positive attitudes towards teams.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 25 Years to 85 Years (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
CLINICIANS
- All clinicians in all of Ohio's CBOCs (except for the Georgetown CBOC) will be eligible for the study (all PCPs have patients with DM in their panel of patients).
PATIENTS
- All diabetic patients who are seen in Ohio's CBOCs (except for the Georgetown CBOC) will be eligible for the study.
Exclusion Criteria:
CLINICIANS
- Any clinician who does not have diabetic patients on their panel, who aren't apart of Ohio's CBOC's, or see patients at the Georgetown CBOC will not be eligible to participate.
PATIENTS
- Patients who don't have a diagnosis of diabetes, who aren't seen at one of Ohio's CBOC's, or is seen for their medical care at the Georgetown CBOC will not be eligible to participate.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00854594
United States, Ohio | |
Louis Stokes VA Medical Center | |
Cleveland, Ohio, United States, 44106-3800 |
Principal Investigator: | Susan R Kirsh, MD | HSR&D Central Office |
Publications of Results:
Responsible Party: | VA Office of Research and Development |
ClinicalTrials.gov Identifier: | NCT00854594 History of Changes |
Other Study ID Numbers: |
EDU 08-414 |
First Posted: | March 3, 2009 Key Record Dates |
Results First Posted: | October 6, 2015 |
Last Update Posted: | October 6, 2015 |
Last Verified: | September 2015 |
Keywords provided by VA Office of Research and Development:
Diabetes Telemedicine Shared Medical Appointments |
Additional relevant MeSH terms:
Diabetes Mellitus Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases |